Health Commission Of The People’s Republic Of China N (2009) National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version). Chin J Cancer Res 30;34:207–237. https://doi.org/10.21147/j.issn.1000-9604.2022.03.04.

Article  CAS  Google Scholar 

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP (2018) Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 10:239–248. https://doi.org/10.2147/CMAR.S149619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al (2022) Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J NatlComprCancNetw 20:167–192. https://doi.org/10.6004/jnccn.2022.0008.

Article  CAS  Google Scholar 

Ao S, Wang Y, Song Q, Ye Y, Lyu G (2021) Current status and future perspectives on neoadjuvant therapy in gastric cancer. Chin J Cancer Res 33:181–192. https://doi.org/10.21147/j.issn.1000-9604.2021.02.06.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwee RM, Kwee TC (2009) Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 12:6–22. https://doi.org/10.1007/s10120-008-0492-5.

Article  CAS  PubMed  Google Scholar 

Wang ZL, Li YL, Li XT, Tang L, Li ZY, Sun YS (2021) Role of CT in the prediction of pathological complete response in gastric cancer after neoadjuvant chemotherapy. AbdomRadiol (NY) 46:3011–3018. https://doi.org/10.1007/s00261-021-02967-3.

Article  Google Scholar 

Li Z, Shan F, Wang Y, Zhang Y, Zhang L, Li S, et al (2018) Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis. PLoS One 13:e0189294. https://doi.org/10.1371/journal.pone.0189294.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwee RM, Kwee TC (2014) Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer. World J Gastroenterol 20:1650–6. https://doi.org/10.3748/wjg.v20.i7.1650.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee IJ, Lee JM, Kim SH, Shin CI, Lee JY, Kim SH, et al (2010) Diagnostic performance of 64-channel multidetector CT in the evaluation of gastric cancer: differentiation of mucosal cancer (T1a) from submucosal involvement (T1b and T2). Radiology 255:805–14. https://doi.org/10.1148/radiol.10091313.

Article  PubMed  Google Scholar 

Giganti F, Tang L, Baba H (2019) Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings. Eur Radiol 29:1743–1753. https://doi.org/10.1007/s00330-018-5732-4.

Article  PubMed  Google Scholar 

Chen CY, Hsu JS, Wu DC, Kang WY, Hsieh JS, Jaw TS, et al (2007) Gastric cancer: preoperative local staging with 3D multi-detector row CT–correlation with surgical and histopathologic results. Radiology. 2007;242:472 – 82. https://doi.org/10.1148/radiol.2422051557.

Fukuya T, Honda H, Hayashi T, Kaneko K, Tateshi Y, Ro T, et al (1995) Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 197:705–11. https://doi.org/10.1148/radiology.197.3.7480743.

Article  CAS  PubMed  Google Scholar 

D’Elia F, Zingarelli A, Palli D, Grani M (2000). Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 10(12):1877–85. https://doi.org/10.1007/s003300000537.

Article  PubMed  Google Scholar 

Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, et al (2004). Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230(2):465–71. https://doi.org/10.1148/radiol.2302020828.

Article  PubMed  Google Scholar 

Kim AY, Kim HJ, Ha HK (2005). Gastric cancer by multidetector row CT: preoperative staging. Abdom Imaging 30(4):465–72. https://doi.org/10.1007/s00261-004-0273-5.

Article  CAS  PubMed  Google Scholar 

Kim HS, Han HY, Choi JA, Park CM, Cha IH, Chung KB, et al (2001). Preoperative evaluation of gastric cancer: value of spiral CT during gastric arteriography (CTGA). Abdom Imaging 26(2):123–30. https://doi.org/10.1007/s002610000167.

Article  CAS  PubMed  Google Scholar 

Kim HJ, Kim AY, Oh ST, Kim JS, Kim KW, Kim PN, et al (2005). Gastric cancer staging at multi-detector row CT gastrography: comparison of transverse and volumetric CT scanning. Radiology 236(3):879–85. https://doi.org/10.1148/radiol.2363041101.

Article  PubMed  Google Scholar 

Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al (2005) Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 103(11):2383–90. https://doi.org/10.1002/cncr.21074.

Article  PubMed  Google Scholar 

Park SR, Lee JS, Kim CG, Kim HK, Kook MC, Kim YW, Ryu KW, Lee JH, Bae JM, Choi IJ (2008) Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer 112:2368–76. https://doi.org/10.1002/cncr.23483.

Article  PubMed  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev ClinOncol. 2017;14:749–762. https://doi.org/10.1038/nrclinonc.2017.141

Dong D, Fang MJ, Tang L, Shan XH, Gao JB, Giganti F, et al (2020) Deep learning radiomicnomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol. 2020;31:912–920. https://doi.org/10.1016/j.annonc.2020.04.003.

Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30:431–438. https://doi.org/10.1093/annonc/mdz001.

Yang J, Wu Q, Xu L, Wang Z, Su K, Liu R, et al (2020) Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer. RadiotherOncol. 2020;150:89–96. https://doi.org/10.1016/j.radonc.2020.06.004.

Jiang Y, Zhang Z, Yuan Q, Wang W, Wang H, Li T, et al (2022) Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. Lancet Digit Health 4:e340-e350. https://doi.org/10.1016/S2589-7500(22)00040-1.

Article  PubMed  Google Scholar 

E A Eisenhauer, P Therasse, J Bogaerts, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45(2):228–47. https://doi.org/10.1016/j.ejca.2008.10.026.

Article  CAS  PubMed  Google Scholar 

Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, et al (2014) Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Ann SurgOncol 21 Suppl 3:S385-9. https://doi.org/10.1245/s10434-014-3615-8.

Article  Google Scholar 

Xuewei Ding, Xuejun Wang, Bin Li, Longgang Wang, Honghai Guo, Liang Shang, et al (2023) PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC). Journal of Clinical Oncology 41:4_suppl, 364–364. https://doi.org/10.1200/JCO.2023.41.4_suppl.364

Article  Google Scholar